Skip to main content

Registration of protocols & results reporting

Regardless of outcome, we disclose the results of our clinical trials in a publicly accessible clinical trials registry.

Access our clinical trials registries online

Our clinical trials registry is available online at Additionally, clinical trial protocol information submitted by AbbVie to the EudraCT database is made publicly available by the EMA via the clinical trials register.


Historical results reporting

Prior to the availability of disclosing clinical trial results for pharmaceuticals on, AbbVie (prior sponsor, Abbott) disclosed certain clinical trial results on the Clinical Study Results Database created by the Pharmaceutical Research and Manufacturers of America (PhRMA), on; however, this database was phased out on December 20, 2011. The clinical trial information previously posted to through August 2011 is available here via the generic name of the product.


What did the PhRMA clinical study results database contain?

The database contained the results from all “hypothesis-testing” clinical studies (mainly Phase III and IV studies) completed since October 1, 2002, for drug products approved in the United States. This included both published articles and unpublished study summaries. This information was presented in a standard format that included the sponsoring company’s name, the proprietary and generic names of the drug, a link or reference to the US Food and Drug Administration (FDA)-approved drug label, the studied indication(s), a bibliography of published studies together with a link (where available) to the printed articles and a summary of the results of clinical studies that have not been published. This summary presentation included information on the drug such as the design of the trial, the number of patients studied, the dose and mode of administration and a summary of conclusions and outcomes on the safety and efficacy of the drug.